Hisamitsu Pharmaceutical Co (Hisamitsu Pharmaceutical Co) Total Stockholders Equity : $1,770.4 Mil (As of Feb. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Hisamitsu Pharmaceutical Co Total Stockholders Equity?

Hisamitsu Pharmaceutical Co's Total Stockholders Equity for the quarter that ended in Feb. 2024 was $1,770.4 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Hisamitsu Pharmaceutical Co's Book Value per Share for the quarter that ended in Feb. 2024 was $23.37. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Hisamitsu Pharmaceutical Co's Debt-to-Equity for the quarter that ended in Feb. 2024 was 0.01.

Hisamitsu Pharmaceutical Co Total Stockholders Equity Historical Data

The historical data trend for Hisamitsu Pharmaceutical Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hisamitsu Pharmaceutical Co Total Stockholders Equity Chart

Hisamitsu Pharmaceutical Co Annual Data

Trend

Feb15

Feb16

Feb17

Feb18

Feb19

Feb20

Feb21

Feb22

Feb23

Feb24

Total Stockholders Equity

Get a 7-Day Free Trial

2,265.49

2,394.20

2,196.16

1,926.86

1,770.35

Hisamitsu Pharmaceutical Co Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Total Stockholders Equity	Get a 7-Day Free Trial															1,926.86	1,892.74	1,884.28	1,797.73	1,770.35

Hisamitsu Pharmaceutical Co (OTCPK:HTSUF) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Hisamitsu Pharmaceutical Co's Book Value per Share for the quarter that ended in Feb. 2024 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(1770.351	-	0)	/	75.7431
	=	23.37

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Hisamitsu Pharmaceutical Co's Debt-to-Equity for the quarter that ended in Feb. 2024 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(9.498	+	4.538)	/	1770.351
	=	0.01

Hisamitsu Pharmaceutical Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Hisamitsu Pharmaceutical Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Hisamitsu Pharmaceutical Co (Hisamitsu Pharmaceutical Co) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hisamitsu Pharmaceutical Co Inc (OTCPK:HTSUF) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

HTSUY:USA 4530:Japan

Address

408 Tashiro Daikan-machi, Tosu, Saga, JPN, 841-0017

Website

http://www.hisamitsu.co.jp

Hisamitsu Pharmaceutical Co Inc is a major pharmaceutical products manufacturer in Japan. The company collaborates with its subsidiaries and associates in operating its business across two segments, The Medical and Related Product segment and the Others segment. The Medical segment represents the company's foremost revenue generating operations. It markets drugs under the Salanpas, Salonsip, Lifecella, Mohrus and Keplat brands, which mainly serve topical medication needs with pain relief creams, gels, sprays, lotions and ointments. The Others segment refers to its miscellaneous businesses such as cable television broadcasting, internet connection, packing materials and insurance. Apart from its primary market in Japan, Hisamitsu has a reach across other regions like North America.

Hisamitsu Pharmaceutical Co (Hisamitsu Pharmaceutical Co) Headlines

No Headlines